BDNF Val66Met polymorphism is associated with negative symptoms in early-onset schizophrenia spectrum and other psychotic disorders


Karacetin G., BAYOĞLU B., Soylemez T. E., Topal M., Koc E. B., Tekden M., ...Daha Fazla

EUROPEAN JOURNAL OF PSYCHIATRY, cilt.36, sa.1, ss.26-34, 2022 (SSCI) identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 36 Sayı: 1
  • Basım Tarihi: 2022
  • Doi Numarası: 10.1016/j.ejpsy.2021.04.002
  • Dergi Adı: EUROPEAN JOURNAL OF PSYCHIATRY
  • Derginin Tarandığı İndeksler: Social Sciences Citation Index (SSCI), Scopus, ASSIA, BIOSIS, EMBASE, Psycinfo, DIALNET
  • Sayfa Sayıları: ss.26-34
  • Anahtar Kelimeler: DRD2/ANKK1 Taq1A genotypes, BDNF Val66Met genotypes, Early-onset schizophrenia, NEUROTROPHIC FACTOR BDNF, D2 RECEPTOR GENE, SERUM-LEVELS, TAQ1A POLYMORPHISM, NO ASSOCIATION, CANNABIS USE, KINASE GENE, DRD2, METAANALYSIS, RISK
  • Dokuz Eylül Üniversitesi Adresli: Evet

Özet

Background and Objectives: To investigate the clinical characteristics of adolescents with early-onset full psychotic disorders either with Brain-derived neurotrophic factor (BDNF) Val66Met (rs6265) or DRD2/ANKK1 Taq1A (rs1800497) polymorphisms.